surmount 2 tirzepatide lowered HbA1c to less than 7% in 90% of patients with #type2diabetes and #obesity. Even more impressive: HbA1c normalized to <5.7% in half of patients 😲. All this with minimal hypoglycemia SURMOUNT-2: Tirzepatide Treatment Leads to

When switching from a pen to a vial, verify your concentration and unit calculations with your provider before the first injection

Cardiovascular Risk Reduction Semaglutide The SELECT trial (n=17,604) demonstrated a 20% reduction in MACE in overweight/obese adults with established CVD

For dogs - who have shorter digestive tracts than humans - this improved delivery mechanism is especially important for getting a meaningful therapeutic dose

They significantly inhibit biofilm metabolic activity and lactic acid production, while drastically reducing biofilm colony-forming units (CFUs)

Can You Stay on a Lower Tirzepatide Dose

Biophys Rev 6(1):4761